Physician

Stephanie Alexandra Kubacak, M.D.

According to 2025 Medicare claims, Stephanie Kubacak, M.D. (NPI: 1821086729) practices internal medicine in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is MCH PROFESSIONAL CARE (NPI: 1649391269; TIN: 92-0192097) and primary practice location at 79765-8607.

Kubacak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 374 traditional Medicare patients, billed 2,590 HCPCS/CPT codes, and received $116,768 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,483 prescription claims across 630 beneficiaries totaling $1,638,717 in drug costs, led by Eliquis (Apixaban). DME data shows 302 claims. Open Payments data shows 42 records totaling $788. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $987,650 to $1,638,717. For DME billing, reported payments moved sharply higher in recent years, from $35,041 to $33,185.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	460	2,996	$135,384
2016	445	5,756	$146,581
2017	426	2,828	$92,158
2018	428	3,844	$123,893
2019	445	3,576	$119,920
2020	421	2,819	$102,320
2021	421	3,381	$137,884
2022	405	5,206	$127,626
2023	398	3,475	$120,750
2024	374	2,590	$116,768

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	535	12,964	$987,650
2016	501	13,471	$1,064,605
2017	551	15,242	$1,200,780
2018	563	15,653	$1,269,513
2019	595	15,060	$1,310,899
2020	613	14,709	$1,256,105
2021	618	14,338	$1,251,946
2022	638	14,659	$1,432,347
2023	644	15,004	$1,695,093
2024	630	15,483	$1,638,717

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	177	609	$24,091
2016	142	530	$21,325
2017	97	437	$12,846
2018	55	368	$10,859
2019	51	287	$9,290
2020	27	209	$11,355
2021	13	195	$13,659
2022	25	216	$16,152
2023	15	291	$22,724
2024	36	302	$23,106

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	351	1,012	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	136	203	$58
90656	Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage	84	84	$22
G0008	Administration of influenza virus vaccine	92	95	$10
96372	Injection of drug or substance under skin or into muscle	100	296	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	224	9,205	$171,512
Rybelsus	Semaglutide	105	4,350	$130,350
Januvia	Sitagliptin Phosphate	106	6,920	$121,363
Ozempic	Semaglutide	104	3,192	$92,347
Mounjaro	Tirzepatide	79	2,380	$86,186

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	26	$13,342
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	12	78	$5,215
E0601	Continuous positive airway pressure (cpap) device	Y	12	58	$1,917
A7030	Full face mask used with positive airway pressure device, each	N	N/R	11	$894
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	60	$763

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$788	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephanie Alexandra Kubacak, M.D.?

Tedicare shows public-source Medicare data for Stephanie Alexandra Kubacak, M.D. (NPI 1821086729), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephanie Alexandra Kubacak, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephanie Alexandra Kubacak, M.D.?

Stephanie Alexandra Kubacak, M.D. is linked to MCH PROFESSIONAL CARE (billing NPI 1649391269) in the available physician profile data.

Does Stephanie Alexandra Kubacak, M.D. have Open Payments data?

Stephanie Alexandra Kubacak, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.